jpad journal
IF 2023 : 8.5

AND option

OR option

Archives

Back to all journals

journal articles

LETTER TO THE EDITOR: CONCERNS ABOUT ANAVEX\'S CLINICAL TRIAL OF BLARCAMESINE

Jesse Brodkin

J Prev Alz Dis 2025;5(12)



CITATION:
Jesse Brodkin (2025): Letter to the Editor: Concerns about Anavex's clinical trial of Blarcamesine. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2025.100137

OPEN ACCESS

Download PDF (668.05 Ko)